ANTI-AGING PRODUCTS AND THERAPIES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-110201 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Anti-aging Products and Therapies Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET
7.1 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA ANTI-AGING PRODUCTS AND THERAPIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Allergan Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Alberto Culver Company
16.3 Avon Products Inc
16.4 Beiersdorf
16.5 Bio Pharma US Corp
16.6 Bayer Schering Pharma AG
16.7 Chanel SA
16.8 Christian Dior
16.9 Clarins
16.10 Elizabeth Arden Inc
16.11 Ella Bache
16.12 Estee Lauder Inc
16.13 F. Hoffmann-La Roche Ltd
16.14 GlaxoSmithKline Plc
16.15 General Nutrition Centers Inc
16.16 Henkel KgaA
16.17 Jan Marini Skin Research Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Active IngredientRetinol
Epidermal growth factors
Peptides
Alpha Hydroxy Acids (AHA’s)
Co-enzyme Q10
Argirelline
Anti-oxidants
Sun Protection Factor (SPF)
Vitamin C
By Products
Natural
Multifunctional
Anti ageing
Anti - wrinkle
Anti - stretch marks
Others
By Therapies and Services
BOTOX
Chemical peels
Injectable skin
Rejuvenation and dermal fillers
Hormone replacement therapy
Telomere based therapy
Gene therapy
 o Proteomics
 o Genomics
 o Predictive medicine
Liposuction
Sclerotherapy
Hair Restoration Services
Eye-Lid Surgery
Abdominoplasty
Anti-Pigmentation Therapy
Breast Augmentation
By End User
Anti-Cellulite Treatment Devices
Microderm Abrasion Devices
Laser Aesthetic Devices
Radiofrequency Devices
Others
Companies
Allergan Inc
Alberto Culver Company
Avon Products Inc
Beiersdorf
Bio Pharma US Corp
Bayer Schering Pharma AG
Chanel SA
Christian Dior
Clarins
Elizabeth Arden Inc
Ella Bache
Estee Lauder Inc
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
General Nutrition Centers Inc
Henkel KgaA
Jan Marini Skin Research Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.